1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GYRE THERAPEUTICS INC
Gyre Therapeutics Inc XNAS: GYRE

Gyre Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Slowing Down Stock
about

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-sta...

Read More
7.21 -0.13 (-1.77%)
62.05% Fall from 52W High
47,516
XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Gyre Therapeutics Inc is on 13 Nov 2025 for the purpose of Gyre Therapeutics Inc Third Quarter Earnings Results for 2025 See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Mid Valuation
30.8 / 100
Momentum Score
Technically Bearish
31.4 / 100
Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM
Analyst Price Target
18
1Yr Price target upside is 150%
3 analysts

3

S

16

W

3

O

2

T

SWOT Analysis

Gyre Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..